Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccordmarketbeat.com
TuHURA Biosciences (NASDAQ:HURA) outlined plans for its late-stage immuno-oncology pipeline at the Canaccord Genuity Growth Conference, highlighting an ongoing Phase III study of IFx in first-line advanced Merkel cell carcinoma, a planned AML trial for its VISTA-inhibiting antibody, and preclinical
Via MarketBeat · August 14, 2026
Comp En De Mn Cemig ADS Q2 Earnings Call Highlightsmarketbeat.com
Comp En De Mn Cemig ADS (NYSE:CIG) reported recurring EBITDA of BRL 2.5 billion for the second quarter of 2026, with recurring EBITDA rising 9.3% from a year earlier and recurring net income increasing 15.6%, according to management during the company’s earnings call. Chief Executive Officer Alexan
Via MarketBeat · August 14, 2026
Live Oak Acquisition Corp. V Q2 Earnings Call Highlightsmarketbeat.com
Live Oak Acquisition Corp. V (NASDAQ:TMS), which operates as Teamshares, said it reaffirmed its 2026 outlook and expects acquisitions to be the primary contributor to growth after completing its Nasdaq listing in June. During its first earnings call as a public company, Teamshares reported that sec
Via MarketBeat · August 14, 2026
Sigma Lithium Q2 Earnings Call Highlightsmarketbeat.com
Sigma Lithium (NASDAQ:SGML) reported record second-quarter revenue and profitability as higher production volumes and lower costs supported margins, while the company also addressed a temporary suspension of mining and industrial operations tied to negotiations with the state of Minas Gerais. Chief
Via MarketBeat · August 14, 2026
Suncrete Q2 Earnings Call Highlightsmarketbeat.com
Suncrete (NASDAQ:RMIX) reported sharply higher second-quarter revenue and adjusted EBITDA as the ready-mix concrete and concrete-products company added five acquisitions and expanded its footprint across Sun Belt markets, while maintaining its full-year 2026 outlook. Revenue rose 146% year over yea
Via MarketBeat · August 14, 2026
Oncobiologics Q3 Earnings Call Highlightsmarketbeat.com
Oncobiologics (NASDAQ:OTLK) said it is preparing for the U.S. commercial launch of LYTENAVA after the Food and Drug Administration approved the product as the only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration, or wet AMD, in the United
Via MarketBeat · August 14, 2026
CSP Q3 Earnings Call Highlightsmarketbeat.com
CSP (NASDAQ:CSPI) reported lower fiscal third-quarter revenue and a wider net loss as longer hardware delivery times delayed the conversion of orders into revenue, while the company continued to build its managed services business and pursue larger enterprise opportunities for its AZT PROTECT cybers
Via MarketBeat · August 14, 2026
Inogen (INGN) Q2 2026 Earnings Call Transcriptfool.com
International sales surged 14.8% as new product categories expanded the addressable market.
Via The Motley Fool · August 14, 2026
Sandisk’s Margins Look Like Software. Can They Last?marketbeat.com
Sandisk's gross margins hit 85% on fixed-price contracts and AI-driven demand, prompting an Argus upgrade, even as bears question if price-led gains can last.
Via MarketBeat · August 14, 2026
Workhorse (WKHS) Q2 2026 Earnings Call Transcriptfool.com
CEO outlines AI data center pivot targeting $41B market opportunity.
Via The Motley Fool · August 14, 2026
Amazon and Alphabet Both Cost More on Next Year's Earnings Than on Last Year'sfool.com
When a stock costs more on next year's earnings than on last year's, profits are usually about to fall. What it means here is stranger.
Via The Motley Fool · August 14, 2026
Orion Properties (ONL) Q2 2026 Earnings Call Transcriptfool.com
Portfolio stabilization efforts drive occupancy gains and debt reduction amid strategic review.
Via The Motley Fool · August 14, 2026
10x Genomics (TXG) Q2 2026 Earnings Call Transcriptfool.com
Atera demand drives spatial transition as booked orders exceed 2026 targets.
Via The Motley Fool · August 14, 2026
Vanguard Is "Cautious" on U.S. Growth Stocks. These 2 Value ETFs Could Be Smarter Buys for Long-Term Investors.fool.com
In the next 10 years, underrated sectors and undervalued companies might beat the biggest names of the AI trade.
Via The Motley Fool · August 14, 2026
Petrobras (PBR) Q2 2026 Earnings Call Transcriptfool.com
Record quarterly profit driven by strong oil prices and operational efficiency gains.
Via The Motley Fool · August 14, 2026
A Top-Notch 7.4% Dividend Stock Paying Cash Every Monthhttps://www.fool.ca/2026/08/14/a-top-notch-7-4-dividend-stock-paying-cash-every-month/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=a80f77e7-c82e-403b-b08a-b3ced2ad61ce
A 7.4% monthly yield can feel like a paycheque, but it only works if AFFO actually covers the distribution.
Via The Motley Fool · August 14, 2026
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcriptfool.com
NERLYNX demand surged 12% year over year as Puma raised full-year guidance.
Via The Motley Fool · August 14, 2026
CAVA Earnings: The Easiest Comp of the Year Meets a Tough Valuationmarketbeat.com
CAVA shares jumped 14% after Q2 2026 results beat estimates with 9% same-restaurant sales growth, though margins slipped and full-year guidance held steady, leaving valuation questions unresolved.
Via MarketBeat · August 14, 2026
Bridgeline Digital (BLIN) Q3 2026 Earnings Call Transcriptfool.com
HawkSearch revenue growth accelerates as company shifts toward AI-powered products.
Via The Motley Fool · August 14, 2026
Elon Musk Says SpaceX Will Generate $1 Trillion in Revenue by 2030. Time to Buy the Stock?fool.com
The stock is about to take off. Or is it?
Via The Motley Fool · August 14, 2026
Strawberry Fields REIT (STRW) Q2 2026 Earnings Call Transcriptfool.com
100% rent collection sustained as management restructures debt and eyes $225M deal pipeline.
Via The Motley Fool · August 14, 2026
Where Will the Vanguard S&P 500 ETF (VOO) Be in 20 Years? Here's What Decades of Stock Market History Suggests.fool.com
Investors who extend their time horizons increase their chances of success.
Via The Motley Fool · August 14, 2026
LanzaTech Global Q2 Earnings Call Highlightsmarketbeat.com
LanzaTech Global (NASDAQ:LNZA) reported second-quarter 2026 revenue that was broadly flat from a year earlier, while sharply lower operating expenses helped narrow its adjusted EBITDA loss as the company continues shifting from an R&D-led model toward project development and commercialization.
Via MarketBeat · August 14, 2026
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipelinemarketbeat.com
Harmony Biosciences (NASDAQ:HRMY) highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its orexin, epilepsy and pitolisant lifecycle-management programs during Piper Sandler’s virtual CNS Symposium. Peter Anastasiou, the company’s chief o
Via MarketBeat · August 14, 2026
Gemini Space Station Q2 Earnings Call Highlightsmarketbeat.com
Gemini Space Station (NASDAQ:GEMI) reported second-quarter revenue growth despite weaker crypto trading activity, as expanding services revenue, over-the-counter trading and new product offerings offset a decline in exchange revenue. The company also highlighted lower operating costs following restr
Via MarketBeat · August 14, 2026